What's driving this
6.1%→2.7% after discontinuing tesamorelin — the February spike confirmed a mast-cell degranulation reaction that is now fully resolved.
Full protocol →Across draws
Eosinophils
| Draw | Value | Status |
|---|---|---|
| June 25, 2026 | 2.7 % | OPTIMAL |
| May 28, 2026 | 4 % | OPTIMAL |
| February 9, 2026 | 6.1 % | HIGH |
| November 21, 2025 | 2 % | OPTIMAL |